QUOTIENT LIMITEDBinding Letter Agreement • September 8th, 2020 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 8th, 2020 Company Industry JurisdictionThis binding letter agreement (“Agreement”) confirms that as of the date set forth above (the “Effective Date”), Quotient Limited (“Quotient”) and Ortho-Clinical Diagnostics, Inc. (“Ortho” and together with Quotient, the “Parties”) have agreed as follows: